Global Point of Care Diagnostics (POCD) Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Industry : HealthcarePublished Date : April 11th, 2018
Tutorials Get 15% Discount on First Report

The global point of care diagnostics market is expected to grow steadily from USD 17.28 billion in 2017 to USD 31.32 billion in 2024, at a CAGR of 8.87% from 2018 to 2024. The growth in the market is attributed to the growing number of infectious disease in developing countries, increasing demand for rapid diagnosis and efficient monitoring solution, and technological advancement such as miniaturization, nanotechnology, and microfluidics, along with new products developments. Moreover, growing demand in urban areas and ease of access & simplistic operation of point of care diagnosis devices is boosting the growth of market. However, stringent government policy for approval may hamper the growth of the market.  The years used for the assessment are as follows:

Historical year: 2014, 2015, 2016

Base year: 2017

Forecast period: 2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total global point of care diagnostics market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global point of care diagnostic market
  • Finalizing the overall size and share of the global point of care diagnostic market

OBJECTIVES:

  • To analyze market trends, opportunities, drivers, and restraints associated with the global point of care diagnostic market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the global point of care diagnostic market and provide their competitive landscape

MARKET SCOPE

The research scope for Global Point of Care Diagnostics Market is as follows:

By Product

  • Blood gas testing
  • Hematology testing
  • Pregnancy and fertility testing
  • Coagulation testing
  • Cholesterol Testing
  • Infection diseases testing
  • Cardiac markers
  • Glucose testing
  • Others

By Mode

  • Over-the-counter (OTC) Testing Kits
  • Prescription-based Testing Kits

By End-user

  • Clinics
  • Home healthcare
  • Diagnostic centers
  • Hospitals
  • Research centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Global Point of Care Diagnostics (POCD) Market size is expected to reach, USD 31.32 billion in 2024, at a CAGR of 8.87% from 2018 to 2024. The growth in the market is attributed to the growing number of infectious disease in developing countries, increasing demand for rapid diagnosis and efficient monitoring solution, and technological advancement such as miniaturization, nanotechnology, and microfluidics, along with new products developments. Moreover, growing demand in urban areas and ease of access & simplistic operation of point of care diagnosis devices is boosting the growth of market. However, stringent government policy for approval may hamper the growth of the industry.

Diagnostic technology has advanced and expanded substantially over the last few years. . The growing demand of POCD in the healthcare industry is helping the doctors and patients to take better decisions since the results are gathering in short span of time mainly near the location of the patient which makes the treatment cheaper. Over the few years, the use of PCOD has increased, the benefit is tremendous. Point of care diagnostics devices are used to diagnose cholesterol, and glucose level, enzyme and electrolyte analysis, testing for infectious diseases, for pregnancy test and among others.  It also plays an important role in patient management, reducing the time and allows rapid treatment to patients. Healthcare researchers are conducting clinical trials for the development of diagnostic devices which is easy to operate and diagnose other critical diseases.

On the basis of product, the glucose monitoring segment hold major share of the market due to growing number of diabetic patients, as well as growing adoption of blood glucose monitoring devices. Based on mode, the prescription-based testing kits held the major share of market in 2017. Based on end-user, the clinics segment held major share of market due to limited laboratory infrastructure in rural areas, availability of diagnostics device in clinics.

Geographically, North America was holding the largest market share in 2017 due to growing prevalence of infectious disease, growing awareness among people. Moreover, new products development as well as government support for the approval of new devices coupled with adoption of the new technology in this region. Asia-Pacific region is expected to witness fastest growth rate during the forecast period owing to growing demand in developing countries such as China and India, and technology advancement in miniaturization, and nanotechnology.

Key players in global point of care diagnostic market are F. Hoffmann-La Roche Ltd; Abbott/Alere; Danaher; Instrumentation Laboratory; Nova Biomedical; Trividia Health, Inc.; Quidel Corporation; Trinity Biotech; Sekisui Diagnostics LLC; OraSure Technologies Inc; Johnson & Johnson Services, Inc, and Becton Dickinson & Company (BD); bioMérieux SA; Abaxis; Siemens Healthineers; QIAGEN

point care diagnostics market

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Point of care diagnostics- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global point of care diagnostics market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Market driver analysis

  3.5.1.1. Growing government support to adoption of new device

  3.5.1.2. Speed of diagnosis and treatment

  3.5.1.3. Growing number of devices approvals

  3.5.1.4. Improving patient outcomes

3.5.2. Market restraint analysis

   3.5.2.1. Failure to detect abnormal results

3.5.3. Industry Analysis-Porters five forces of analysis

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis

4.2. Competitive factors

4.3. Strategies adopted

CHAPTER 5. Global Point of Care Diagnostics (POCD) Market Size and Forecast (2014 – 2024)

5.1. Global Point of Care Diagnostics (POCD) Market, By Product

5.1.1. Blood Gas Testing

5.1.2. Hematology Testing

5.1.3. Pregnancy and Fertility Testing

5.1.4. Coagulation Testing

5.1.5. Cholesterol Testing

5.1.6. Infection Diseases testing

5.1.7. Cardiac Markers

5.1.8. Glucose Testing

5.1.9. Others

5.2. Global Point of Care Diagnostics (POCD) Market, By Mode

5.2.1. Over-the-counter (OTC) Testing Kits

5.2.2. Prescription-based Testing Kits

5.3. Global Point of Care Diagnostics (POCD) Market, By End-User

5.3.1. Clinics

5.3.2. Home Healthcare

5.3.3. Diagnostic Centers

5.3.4. Hospitals

5.3.5. Research Centers

5.4. Global Point of Care Diagnostics (POCD) Market, By Region

5.4.1. North America

5.4.2. Europe

5.4.3. Asia-Pacific

5.4.4. Rest of the World (RoW)

CHAPTER 6. Global Point of Care Diagnostics (POCD) Market, By Geography

6.1. North America Point of Care Diagnostics (POCD) Market

6.1.1. North America Point of Care Diagnostics (POCD) Market, By Product (USD Billion)

6.1.2. North America Point of Care Diagnostics (POCD) Market, By Mode (USD Billion)

6.1.3. North America Point of Care Diagnostics (POCD) Market, By End-user (USD Billion)

6.1.4. North America Point of Care Diagnostics (POCD) Market, By Country

   6.1.4.1. U.S.

  6.1.4.2. Canada

  6.1.4.3. Mexico

6.2. Europe Point of Care Diagnostics (POCD) Market

6.2.1. Europe Point of Care Diagnostics (POCD) Market, By Product (USD Billion)

6.2.2. Europe Point of Care Diagnostics (POCD) Market, By Mode (USD Billion)

6.2.3. Europe Point of Care Diagnostics (POCD) Market, By End-user (USD Billion)

6.2.4. Europe Point of Care Diagnostics (POCD) Market, By Country

   6.2.4.1. Germany

  6.2.4.2. France

  6.2.4.3. U.K.

  6.2.4.4. Italy

  6.2.4.5. Spain

  6.2.4.6. Rest of Europe

6.3. Asia-Pacific Point of Care Diagnostics (POCD) Market

6.3.1. Asia-Pacific Point of Care Diagnostics (POCD) Market, By Product (USD Billion)

6.3.2. Asia-Pacific Point of Care Diagnostics (POCD) Market, By Mode (USD Billion)

6.3.3. Asia-Pacific Point of Care Diagnostics (POCD) Market, By End-User (USD Billion)

6.3.4. Asia-Pacific Point of Care Diagnostics (POCD) Market, By Country

  6.3.4.1. China

  6.3.4.2. Australia

  6.3.4.3. Japan

  6.3.4.4. Singapore

  6.3.4.5. India

  6.3.4.6. Rest of Asia-Pacific

6.4. Rest of the World (RoW) Point of Care Diagnostics (POCD) Market

6.4.1. Middle East and Africa Point of Care Diagnostics (POCD) Market, By Product (USD Billion)

6.4.2. Middle East and Africa Point of Care Diagnostics (POCD) Market, By Mode (USD Billion)

6.4.3. Middle East and Africa Point of Care Diagnostics (POCD) Market, By End-User (USD Billion)

6.4.4. Middle East and Africa Point of Care Diagnostics (POCD) Market, By Region

   6.4.4.1. Middle East and Africa (MEA)

   6.4.4.2. Latin America

CHAPTER 7. Key Players and Strategic Developments

7.1. Roche Diagnostics

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Abbott Diagnostics Inc.

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Abaxis Inc.

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Spectral Diagnostics

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. Siemens Healthcare

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Johnson & Johnson

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Nova Biomedical

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Chembio Diagnostic Systems, Inc.

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. OraSure Technologies, Inc.

 7.9.1. Business Overview

 7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. Abbreviation

Global Point of Care Diagnostics (POCD) Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation Forecast 2024